Literature DB >> 11252339

In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.

F Barchiesi1, A M Tortorano, L F Di Francesco, M Cogliati, G Scalise, M A Viviani.   

Abstract

A broth microdilution method and an agar dilution method were used for testing fluconazole, itraconazole, ketoconazole, flucytosine and amphotericin B against 98 clinical isolates belonging to seven species of Candida. The approximate rank order of fluconazole MICs was Candida lusitaniae approximately Candida kefyr < Candida famata approximately Candida guilliermondii < Candida pelliculosa approximately C. lipolytica approximately Candida inconspicua. Candida lypolitica and C. pelliculosa were the species least susceptible to itraconazole and ketoconazole. Flucytosine MICs revealed the highest prevalence of resistant strains among C. lipolytica and C. lusitaniae. All isolates were susceptible to amphotericin B.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11252339     DOI: 10.1093/jac/43.2.295

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  11 in total

1.  Antifungal drug susceptibility profile of Pichia anomala isolates from patients presenting with nosocomial fungemia.

Authors:  Vânia Lúcia Ribeiro da Matta; Márcia de Souza Carvalho Melhem; Arnaldo Lopes Colombo; Maria Luiza Moretti; Laura Rodero; Gisele Madeira Duboc de Almeida; Marilena dos Anjos Martins; Silvia Figueiredo Costa; Maria Beatriz G Souza Dias; Márcio Nucci; Anna S Levin
Journal:  Antimicrob Agents Chemother       Date:  2007-01-29       Impact factor: 5.191

2.  Antifungal activities of R-135853, a sordarin derivative, in experimental candidiasis in mice.

Authors:  Yasuki Kamai; Masayo Kakuta; Takahiro Shibayama; Takashi Fukuoka; Shogo Kuwahara
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

3.  In vitro and in vivo activities of CS-758 (R-120758), a new triazole antifungal agent.

Authors:  Yasuki Kamai; Tamako Harasaki; Takashi Fukuoka; Satoshi Ohya; Katsuhisa Uchida; Hideyo Yamaguchi; Shogo Kuwahara
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

4.  Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750.

Authors:  F Barchiesi; D Calabrese; D Sanglard; L Falconi Di Francesco; F Caselli; D Giannini; A Giacometti; S Gavaudan; G Scalise
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

5.  In vitro activities of the new antifungal triazole SCH 56592 against common and emerging yeast pathogens.

Authors:  F Barchiesi; D Arzeni; A W Fothergill; L F Di Francesco; F Caselli; M G Rinaldi; G Scalise
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

6.  In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.

Authors:  D J Diekema; S A Messer; L B Boyken; R J Hollis; J Kroeger; S Tendolkar; M A Pfaller
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

7.  In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood.

Authors:  M A Pfaller; D J Diekema; S A Messer; L Boyken; R J Hollis; R N Jones
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

8.  Candida famata mediastinitis. A rare complication of open heart surgery. Case report and brief review.

Authors:  Alfredo Alonso Sanchez Betancourt; Pablo Sibaja Alvarez; Rolando Arguedas Camacho; Edward Guevara Espinoza
Journal:  IDCases       Date:  2016-07-04

9.  Wickerhamomyces anomalous: A Rare Cause of Fungemia Causing Febrile Neutropenia in Acute Lymphoblastic Leukemia.

Authors:  Vibha Mehta; Aroop Mohanty; Suneeta Meena; J S Rahul; Nath Uttam Kumar; Debranjani Chattopadhyay; Anamika Bakliwal; Ranjana Choudhary; Pratima Gupta
Journal:  Case Rep Infect Dis       Date:  2020-12-29

10.  Candida kefyr in Kuwait: Prevalence, antifungal drug susceptibility and genotypic heterogeneity.

Authors:  Suhail Ahmad; Ziauddin Khan; Noura Al-Sweih; Wadha Alfouzan; Leena Joseph; Mohammad Asadzadeh
Journal:  PLoS One       Date:  2020-10-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.